Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 14 | 2024 | 236 | 6.570 |
Why?
|
| Stress Disorders, Post-Traumatic | 30 | 2025 | 397 | 4.760 |
Why?
|
| Microbiota | 7 | 2025 | 129 | 4.200 |
Why?
|
| Dysbiosis | 7 | 2024 | 65 | 2.850 |
Why?
|
| Alzheimer Disease | 7 | 2024 | 721 | 2.420 |
Why?
|
| Frailty | 4 | 2022 | 130 | 2.360 |
Why?
|
| Feces | 6 | 2024 | 112 | 2.340 |
Why?
|
| Anti-Bacterial Agents | 8 | 2022 | 787 | 1.950 |
Why?
|
| Emergency Service, Hospital | 16 | 2025 | 1090 | 1.780 |
Why?
|
| Soft Tissue Infections | 4 | 2020 | 49 | 1.680 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2020 | 89 | 1.660 |
Why?
|
| Asymptomatic Infections | 2 | 2025 | 29 | 1.620 |
Why?
|
| Urinary Tract Infections | 2 | 2025 | 91 | 1.600 |
Why?
|
| Nursing Homes | 6 | 2024 | 666 | 1.310 |
Why?
|
| Clostridium Infections | 2 | 2021 | 49 | 1.190 |
Why?
|
| Metagenomics | 3 | 2024 | 28 | 1.130 |
Why?
|
| Aged | 26 | 2025 | 14330 | 1.070 |
Why?
|
| Aging | 2 | 2024 | 746 | 1.040 |
Why?
|
| Humans | 73 | 2025 | 63176 | 1.000 |
Why?
|
| Urine | 1 | 2025 | 45 | 0.940 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2016 | 34 | 0.940 |
Why?
|
| Diarrhea | 2 | 2016 | 76 | 0.920 |
Why?
|
| Pneumonia, Bacterial | 2 | 2018 | 89 | 0.920 |
Why?
|
| Male | 42 | 2025 | 29727 | 0.920 |
Why?
|
| Female | 44 | 2025 | 32726 | 0.890 |
Why?
|
| Cognitive Dysfunction | 3 | 2024 | 333 | 0.880 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 158 | 0.860 |
Why?
|
| Weevils | 1 | 2023 | 1 | 0.860 |
Why?
|
| Bacteria | 5 | 2025 | 305 | 0.830 |
Why?
|
| Prospective Studies | 15 | 2025 | 3267 | 0.780 |
Why?
|
| Influenza, Human | 3 | 2014 | 208 | 0.780 |
Why?
|
| Adult | 35 | 2025 | 16735 | 0.770 |
Why?
|
| Guideline Adherence | 3 | 2020 | 306 | 0.760 |
Why?
|
| Inflammation | 4 | 2024 | 1148 | 0.720 |
Why?
|
| Middle Aged | 30 | 2025 | 17476 | 0.710 |
Why?
|
| Treatment Failure | 3 | 2021 | 199 | 0.710 |
Why?
|
| Fear | 3 | 2025 | 70 | 0.650 |
Why?
|
| Polysaccharides | 1 | 2021 | 144 | 0.640 |
Why?
|
| Skin Diseases, Infectious | 2 | 2016 | 12 | 0.630 |
Why?
|
| Inappropriate Prescribing | 1 | 2020 | 66 | 0.620 |
Why?
|
| Aged, 80 and over | 10 | 2025 | 5429 | 0.620 |
Why?
|
| Depressive Disorder, Major | 4 | 2023 | 255 | 0.610 |
Why?
|
| White Matter | 3 | 2025 | 123 | 0.610 |
Why?
|
| Young Adult | 20 | 2025 | 4669 | 0.580 |
Why?
|
| Longitudinal Studies | 13 | 2025 | 1254 | 0.580 |
Why?
|
| Macrolides | 1 | 2018 | 38 | 0.570 |
Why?
|
| Antacids | 1 | 2017 | 12 | 0.560 |
Why?
|
| Community-Acquired Infections | 1 | 2018 | 94 | 0.550 |
Why?
|
| Independent Living | 1 | 2017 | 51 | 0.540 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 733 | 0.540 |
Why?
|
| Bacterial Infections | 2 | 2023 | 149 | 0.540 |
Why?
|
| Nutritional Status | 1 | 2017 | 97 | 0.540 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2025 | 2159 | 0.530 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 180 | 0.500 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2015 | 9 | 0.490 |
Why?
|
| Outpatients | 1 | 2016 | 141 | 0.480 |
Why?
|
| Marijuana Use | 2 | 2025 | 21 | 0.460 |
Why?
|
| Mediator Complex | 1 | 2014 | 13 | 0.460 |
Why?
|
| Hyphae | 1 | 2014 | 16 | 0.460 |
Why?
|
| Neoplasms | 1 | 2025 | 1358 | 0.450 |
Why?
|
| Hemagglutinins, Viral | 1 | 2014 | 12 | 0.450 |
Why?
|
| Administration, Intravenous | 1 | 2014 | 66 | 0.440 |
Why?
|
| RNA, Ribosomal, 16S | 4 | 2023 | 87 | 0.440 |
Why?
|
| Candida albicans | 1 | 2014 | 72 | 0.440 |
Why?
|
| Reward | 2 | 2024 | 87 | 0.430 |
Why?
|
| Fungal Proteins | 1 | 2014 | 147 | 0.430 |
Why?
|
| Antibodies, Viral | 2 | 2023 | 325 | 0.420 |
Why?
|
| Cohort Studies | 7 | 2025 | 2561 | 0.420 |
Why?
|
| Respiratory Tract Infections | 1 | 2014 | 89 | 0.420 |
Why?
|
| Wearable Electronic Devices | 2 | 2024 | 67 | 0.400 |
Why?
|
| Heart Rate | 2 | 2024 | 321 | 0.400 |
Why?
|
| Accidents, Traffic | 6 | 2022 | 146 | 0.380 |
Why?
|
| Alcohol Drinking | 2 | 2025 | 314 | 0.370 |
Why?
|
| Machine Learning | 3 | 2024 | 177 | 0.370 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 165 | 0.360 |
Why?
|
| Virus Diseases | 1 | 2012 | 119 | 0.360 |
Why?
|
| Survivors | 4 | 2025 | 170 | 0.360 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2022 | 715 | 0.350 |
Why?
|
| Biomarkers | 4 | 2025 | 1392 | 0.330 |
Why?
|
| Severity of Illness Index | 4 | 2024 | 1542 | 0.320 |
Why?
|
| Amygdala | 3 | 2024 | 83 | 0.320 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2025 | 74 | 0.310 |
Why?
|
| Prefrontal Cortex | 3 | 2024 | 122 | 0.310 |
Why?
|
| Risk Factors | 8 | 2025 | 5327 | 0.310 |
Why?
|
| Wrist | 3 | 2024 | 38 | 0.300 |
Why?
|
| Cytokines | 1 | 2013 | 934 | 0.300 |
Why?
|
| Wounds and Injuries | 2 | 2021 | 247 | 0.300 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 734 | 0.300 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2014 | 90 | 0.300 |
Why?
|
| Depression | 7 | 2023 | 890 | 0.290 |
Why?
|
| Brain | 7 | 2024 | 1553 | 0.280 |
Why?
|
| Pain | 3 | 2023 | 404 | 0.280 |
Why?
|
| Motor Vehicles | 6 | 2023 | 31 | 0.280 |
Why?
|
| Health Personnel | 2 | 2021 | 367 | 0.270 |
Why?
|
| Bacteriuria | 1 | 2025 | 16 | 0.240 |
Why?
|
| Urinalysis | 1 | 2025 | 38 | 0.240 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2025 | 40 | 0.240 |
Why?
|
| Basolateral Nuclear Complex | 1 | 2025 | 7 | 0.240 |
Why?
|
| Psychological Trauma | 2 | 2024 | 21 | 0.240 |
Why?
|
| Galvanic Skin Response | 1 | 2025 | 24 | 0.230 |
Why?
|
| Autonomic Nervous System | 1 | 2025 | 36 | 0.230 |
Why?
|
| Prognosis | 3 | 2025 | 1739 | 0.230 |
Why?
|
| ROC Curve | 3 | 2021 | 281 | 0.230 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2025 | 47 | 0.230 |
Why?
|
| Equol | 1 | 2024 | 5 | 0.230 |
Why?
|
| Animals | 8 | 2025 | 20647 | 0.230 |
Why?
|
| Tobacco Use | 1 | 2025 | 39 | 0.230 |
Why?
|
| Binge Drinking | 1 | 2025 | 37 | 0.230 |
Why?
|
| Mouth | 1 | 2024 | 35 | 0.230 |
Why?
|
| Adolescent | 8 | 2025 | 6226 | 0.230 |
Why?
|
| Metabolomics | 1 | 2024 | 53 | 0.220 |
Why?
|
| Pollination | 1 | 2023 | 3 | 0.210 |
Why?
|
| Flowers | 1 | 2023 | 5 | 0.210 |
Why?
|
| Income | 1 | 2025 | 169 | 0.210 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 60 | 0.210 |
Why?
|
| Estradiol | 1 | 2025 | 257 | 0.210 |
Why?
|
| Massachusetts | 3 | 2024 | 2074 | 0.210 |
Why?
|
| Symbiosis | 1 | 2023 | 32 | 0.210 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2025 | 96 | 0.210 |
Why?
|
| Plants | 1 | 2023 | 49 | 0.210 |
Why?
|
| Gray Matter | 1 | 2023 | 35 | 0.210 |
Why?
|
| Internal Capsule | 1 | 2023 | 11 | 0.210 |
Why?
|
| Longevity | 1 | 2024 | 113 | 0.200 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 935 | 0.200 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2023 | 13 | 0.200 |
Why?
|
| Residence Characteristics | 1 | 2024 | 220 | 0.200 |
Why?
|
| Computational Biology | 1 | 2025 | 355 | 0.200 |
Why?
|
| Biological Availability | 1 | 2023 | 200 | 0.200 |
Why?
|
| Chronic Pain | 1 | 2025 | 151 | 0.200 |
Why?
|
| Dreams | 1 | 2022 | 3 | 0.200 |
Why?
|
| Dissociative Disorders | 1 | 2022 | 8 | 0.200 |
Why?
|
| Cannabis | 1 | 2023 | 51 | 0.190 |
Why?
|
| Sex Characteristics | 1 | 2024 | 203 | 0.190 |
Why?
|
| Acute Pain | 1 | 2022 | 21 | 0.190 |
Why?
|
| Prevalence | 3 | 2021 | 1375 | 0.190 |
Why?
|
| Phylogeny | 1 | 2023 | 376 | 0.190 |
Why?
|
| Sex Factors | 3 | 2025 | 977 | 0.190 |
Why?
|
| Alcoholism | 1 | 2025 | 318 | 0.190 |
Why?
|
| Smartphone | 1 | 2023 | 69 | 0.190 |
Why?
|
| Logistic Models | 2 | 2016 | 1274 | 0.190 |
Why?
|
| Child Abuse | 1 | 2023 | 88 | 0.190 |
Why?
|
| Functional Neuroimaging | 1 | 2021 | 14 | 0.190 |
Why?
|
| Social Support | 1 | 2024 | 371 | 0.190 |
Why?
|
| Insulins | 1 | 2022 | 15 | 0.190 |
Why?
|
| Blood Pressure | 1 | 2024 | 510 | 0.180 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 165 | 0.180 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 17 | 0.180 |
Why?
|
| Human Development | 1 | 2020 | 9 | 0.180 |
Why?
|
| Abscess | 1 | 2021 | 79 | 0.170 |
Why?
|
| Health | 1 | 2020 | 31 | 0.170 |
Why?
|
| Drainage | 1 | 2021 | 154 | 0.170 |
Why?
|
| Proton Pump Inhibitors | 1 | 2021 | 42 | 0.170 |
Why?
|
| Diet | 1 | 2024 | 526 | 0.170 |
Why?
|
| Virus Replication | 1 | 2002 | 319 | 0.170 |
Why?
|
| Monocytes | 1 | 2002 | 353 | 0.160 |
Why?
|
| Sleep Wake Disorders | 1 | 2021 | 69 | 0.160 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2019 | 8 | 0.160 |
Why?
|
| Models, Theoretical | 1 | 2021 | 268 | 0.160 |
Why?
|
| Psychometrics | 1 | 2021 | 375 | 0.160 |
Why?
|
| Anxiety | 4 | 2023 | 423 | 0.160 |
Why?
|
| Self Care | 1 | 2021 | 212 | 0.150 |
Why?
|
| Occupational Diseases | 1 | 2021 | 268 | 0.150 |
Why?
|
| Ambulatory Care | 1 | 2021 | 311 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 87 | 0.150 |
Why?
|
| Intestines | 1 | 2019 | 167 | 0.140 |
Why?
|
| United States | 5 | 2025 | 7821 | 0.140 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 2573 | 0.130 |
Why?
|
| Paracentesis | 1 | 2016 | 12 | 0.130 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 2190 | 0.130 |
Why?
|
| HIV-1 | 1 | 2002 | 721 | 0.130 |
Why?
|
| Epithelial Cells | 1 | 2019 | 390 | 0.130 |
Why?
|
| Homeostasis | 1 | 2019 | 370 | 0.130 |
Why?
|
| Multicenter Studies as Topic | 1 | 2016 | 136 | 0.130 |
Why?
|
| Age Distribution | 1 | 2016 | 259 | 0.120 |
Why?
|
| Telemedicine | 1 | 2021 | 323 | 0.120 |
Why?
|
| Recurrence | 1 | 2017 | 639 | 0.120 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 417 | 0.120 |
Why?
|
| Dementia | 1 | 2019 | 257 | 0.120 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 732 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 1143 | 0.120 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 497 | 0.120 |
Why?
|
| HIV Infections | 1 | 2002 | 968 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2023 | 1121 | 0.110 |
Why?
|
| Algorithms | 1 | 2020 | 1001 | 0.110 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2014 | 9 | 0.110 |
Why?
|
| Virulence | 1 | 2014 | 195 | 0.110 |
Why?
|
| Antibody Formation | 1 | 2014 | 113 | 0.110 |
Why?
|
| Mental Disorders | 1 | 2021 | 788 | 0.110 |
Why?
|
| HLA-DR3 Antigen | 1 | 2013 | 7 | 0.110 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2014 | 127 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 296 | 0.100 |
Why?
|
| Femoral Nerve | 1 | 2013 | 9 | 0.100 |
Why?
|
| Administration, Oral | 1 | 2014 | 369 | 0.100 |
Why?
|
| Morphine | 1 | 2013 | 59 | 0.100 |
Why?
|
| Escherichia coli | 1 | 2017 | 700 | 0.100 |
Why?
|
| Psychopathology | 2 | 2023 | 21 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 213 | 0.100 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2013 | 181 | 0.100 |
Why?
|
| Nerve Block | 1 | 2013 | 51 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 209 | 0.100 |
Why?
|
| Influenza Vaccines | 1 | 2013 | 99 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2014 | 769 | 0.100 |
Why?
|
| Hip Fractures | 1 | 2013 | 76 | 0.090 |
Why?
|
| Trauma Centers | 1 | 2012 | 123 | 0.090 |
Why?
|
| Age Factors | 1 | 2015 | 1559 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 608 | 0.090 |
Why?
|
| Pain Management | 1 | 2013 | 159 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2021 | 6595 | 0.090 |
Why?
|
| Anxiety Disorders | 2 | 2023 | 192 | 0.080 |
Why?
|
| Neuroimaging | 2 | 2022 | 153 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2021 | 5623 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 969 | 0.080 |
Why?
|
| Emergency Medical Services | 1 | 2013 | 263 | 0.080 |
Why?
|
| Disease Progression | 1 | 2014 | 1167 | 0.080 |
Why?
|
| Cognition | 2 | 2024 | 484 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 641 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1082 | 0.080 |
Why?
|
| Infant, Newborn | 2 | 2023 | 1355 | 0.080 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 436 | 0.080 |
Why?
|
| Paecilomyces | 1 | 2008 | 2 | 0.070 |
Why?
|
| Bursitis | 1 | 2008 | 17 | 0.070 |
Why?
|
| Mycoses | 1 | 2008 | 46 | 0.070 |
Why?
|
| Mutation | 1 | 2014 | 2608 | 0.060 |
Why?
|
| Child | 3 | 2022 | 4517 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 1278 | 0.060 |
Why?
|
| Ultrasonography | 2 | 2021 | 481 | 0.060 |
Why?
|
| Reflex, Startle | 1 | 2025 | 8 | 0.060 |
Why?
|
| Vaccines, Combined | 1 | 2023 | 9 | 0.050 |
Why?
|
| Hypothalamus | 1 | 2024 | 132 | 0.050 |
Why?
|
| Hydroxy Acids | 1 | 2023 | 2 | 0.050 |
Why?
|
| Bacteroides fragilis | 1 | 2023 | 5 | 0.050 |
Why?
|
| Bacteroides | 1 | 2023 | 9 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 622 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2023 | 43 | 0.050 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 531 | 0.050 |
Why?
|
| Anisotropy | 1 | 2023 | 60 | 0.050 |
Why?
|
| Nucleocapsid Proteins | 1 | 2023 | 36 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2023 | 52 | 0.050 |
Why?
|
| Gyrus Cinguli | 1 | 2023 | 57 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 392 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2024 | 260 | 0.050 |
Why?
|
| Nerve Net | 1 | 2023 | 97 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2025 | 777 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2002 | 96 | 0.050 |
Why?
|
| Mice | 3 | 2023 | 10841 | 0.050 |
Why?
|
| Hippocampus | 1 | 2024 | 270 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2023 | 113 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2022 | 28 | 0.050 |
Why?
|
| Biological Variation, Individual | 1 | 2021 | 3 | 0.050 |
Why?
|
| Precipitating Factors | 1 | 2021 | 3 | 0.050 |
Why?
|
| Psychophysiology | 1 | 2021 | 7 | 0.050 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 40 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2023 | 455 | 0.050 |
Why?
|
| Trauma Severity Indices | 1 | 2021 | 34 | 0.050 |
Why?
|
| Immunization, Secondary | 1 | 2021 | 45 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2022 | 85 | 0.050 |
Why?
|
| Comorbidity | 1 | 2025 | 1118 | 0.050 |
Why?
|
| Immunization Schedule | 1 | 2021 | 18 | 0.050 |
Why?
|
| Rats | 1 | 2025 | 1980 | 0.050 |
Why?
|
| Life Change Events | 1 | 2021 | 66 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 468 | 0.040 |
Why?
|
| Self Report | 1 | 2023 | 374 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2021 | 391 | 0.040 |
Why?
|
| Microglia | 1 | 2023 | 242 | 0.040 |
Why?
|
| Vaccination | 1 | 2023 | 363 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2021 | 517 | 0.040 |
Why?
|
| Sleep | 1 | 2023 | 224 | 0.040 |
Why?
|
| Emotions | 1 | 2022 | 223 | 0.040 |
Why?
|
| Military Personnel | 1 | 2019 | 118 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2023 | 1536 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2021 | 382 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 2671 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2066 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 43 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2013 | 22 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2013 | 241 | 0.030 |
Why?
|
| New England | 1 | 2013 | 273 | 0.030 |
Why?
|
| Analgesia | 1 | 2013 | 31 | 0.030 |
Why?
|
| Viral Load | 1 | 2013 | 231 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 177 | 0.020 |
Why?
|
| Veterans | 1 | 2019 | 764 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2013 | 519 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1648 | 0.020 |
Why?
|
| Ketoconazole | 1 | 2008 | 8 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Fungal | 1 | 2008 | 4 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 1985 | 0.020 |
Why?
|
| Lung | 1 | 2013 | 952 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2008 | 107 | 0.020 |
Why?
|